These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33123538)

  • 1. PAQR3 Inhibits Non-small Cell Lung Cancer Growth by Regulating the NF-κB/p53/Bax Axis.
    Guo Q; Ke XX; Fang SX; Gao WL; Song YX; Chen C; Lu HL; Xu G
    Front Cell Dev Biol; 2020; 8():581919. PubMed ID: 33123538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAQR3 inhibits proliferation via suppressing PI3K/AKT signaling pathway in non-small cell lung cancer.
    Li X; Li M; Chen D; Shi G; Zhao H
    Arch Med Sci; 2018 Oct; 14(6):1289-1297. PubMed ID: 30393483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestin and AdipoQ Receptor 3 Upregulates Fibronectin and Intercellular Adhesion Molecule-1 in Glomerular Mesangial Cells
    Zou Y; Chen Z; Li J; Gong W; Zhang L; Xu F; Chen L; Liu P; Huang H
    Front Endocrinol (Lausanne); 2018; 9():275. PubMed ID: 29930535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAQR3 regulates phosphorylation of FoxO1 in insulin-resistant HepG2 cells via NF-κB signaling pathway.
    Chen L; Sun X; Xiao H; Xu F; Yang Y; Lin Z; Chen Z; Quan S; Huang H
    Exp Cell Res; 2019 Aug; 381(2):301-310. PubMed ID: 31095939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma.
    Wu HG; Zhang WJ; Ding Q; Peng G; Zou ZW; Liu T; Cao RB; Fei SJ; Li PC; Yang KY; Hu JL; Dai XF; Wu G; Li PD
    Oncol Rep; 2014 Dec; 32(6):2687-95. PubMed ID: 25310770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling.
    Bai G; Chu J; Eli M; Bao Y; Wen H
    Biomed Pharmacother; 2017 Oct; 94():813-819. PubMed ID: 28802234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
    Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE
    Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAQR3 inhibits proliferation and aggravates ferroptosis in acute lymphoblastic leukemia through modulation Nrf2 stability.
    Jin L; Tong L
    Immun Inflamm Dis; 2021 Sep; 9(3):827-839. PubMed ID: 33955706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAQR3 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer Cells.
    Zhou F; Wang S; Wang J
    Oncol Res; 2017 May; 25(5):663-671. PubMed ID: 28548040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrined leptin promotes proliferation of non-small cell lung cancer (NSCLC) via
    Wang J; Zhou F; Li F; Wang B; Hu Y; Li X
    Ann Transl Med; 2021 Apr; 9(7):568. PubMed ID: 33987266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DRAM2 acts as an oncogene in non-small cell lung cancer and suppresses the expression of p53.
    Wudu M; Ren H; Hui L; Jiang J; Zhang S; Xu Y; Wang Q; Su H; Jiang X; Dao R; Qiu X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):72. PubMed ID: 30755245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emerging Roles and Mechanisms of PAQR3 in Human Cancer: Pathophysiology and Therapeutic Implications.
    Guo Q; Liu XL; Zhai K; Chen C; Ke XX; Zhang J; Xu G
    Int J Gen Med; 2023; 16():4321-4328. PubMed ID: 37767187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of PAQR3 gene promoter hypermethylation in breast cancer and prognosis.
    Chen J; Wang F; Xu J; He Z; Lu Y; Wang Z
    Oncol Rep; 2016 Sep; 36(3):1612-8. PubMed ID: 27461225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
    Han Y; Tian H; Chen P; Lin Q
    Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpressed D2 Dopamine Receptor Inhibits Non-Small Cell Lung Cancer Progression through Inhibiting NF-κB Signaling Pathway.
    Wu XY; Zhang CX; Deng LC; Xiao J; Yuan X; Zhang B; Hou ZB; Sheng ZH; Sun L; Jiang QC; Zhao W
    Cell Physiol Biochem; 2018; 48(6):2258-2272. PubMed ID: 30114693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAQR3 inhibits the proliferation, migration and invasion in human glioma cells.
    Tang SL; Gao YL; Hu WZ
    Biomed Pharmacother; 2017 Aug; 92():24-32. PubMed ID: 28528182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.
    Xing Y; Liu Y; Liu T; Meng Q; Lu H; Liu W; Hu J; Li C; Cao M; Yan S; Huang J; Wang T; Cai L
    Cell Commun Signal; 2018 Jul; 16(1):43. PubMed ID: 30064446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAQR3 plays a suppressive role in the tumorigenesis of colorectal cancers.
    Wang X; Li X; Fan F; Jiao S; Wang L; Zhu L; Pan Y; Wu G; Ling ZQ; Fang J; Chen Y
    Carcinogenesis; 2012 Nov; 33(11):2228-35. PubMed ID: 22828136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor PAQR3 associated with the clinical significance and prognosis in esophageal squamous cell carcinoma.
    Bai G; Yang M; Zheng C; Zhang L; Eli M
    Oncol Lett; 2018 Apr; 15(4):5703-5711. PubMed ID: 29552204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.